Hemofarm’s prescription drugs, called Rx drugs, are the most common products in the pharmaceutical market of Serbia
Hemofarm's prescription drugs, known as Rx, are the most represented products in the pharmaceutical market of Serbia.
The portfolio includes 13 out of a total of 14 pharmacotherapeutic groups, covering a wide range of diagnostic indications.
Hemofarm's leading Rx products in Serbia (by INN) are:
- OCRELIZUMAB
- BROMAZEPAM
- RIVAROXABAN
- LORAZEPAM
- METFORMIN
- DICLOFENAC
- AMOXICILLIN, CLAVULANIC ACID
- SODIUM CHLORIDE
- ACETYLSALICYLIC ACID
- AZITHROMYCIN
Hemofarm products that require a doctor’s prescription are listed in a table. You can organize the table according to the active substance, the protected (brand) name of the medicine, or the therapeutic group.
The information about the medicines available on this website represents updated data approved by the Agency for Medicines and Medical Devices of Serbia, in accordance with the current legislation. In the event of any discrepancy between the data provided on the website and the content of the printed Patient Information Leaflet, the information published on the website is considered to be more recent. The content on the website is intended solely for informational purposes and cannot replace the professional advice of a doctor or pharmacist.